Records containing: Sickle Cell Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-05-03Endothelial Monocyte-activating Polypeptide-II as an Endothelial Dysfunction Marker and Its Relation to the Oxidative Stress in Egyptian Sickle Patients
-
CLINICAL_TRIALS study record update · 2023-05-01Neurovascular Determinants of Cognitive Function in Adults With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2023-05-01Assessment of Genetic and Haematological Modifiers of Disease Severity Among Patients With Sickle Cell Disease (SCD) in Kaduna State, Northern Nigeria
-
CLINICAL_TRIALS study record update · 2023-04-27Patient Characteristics and Treatment Patterns From Early Crizanlizumab Use in Real-world Setting: Preliminary Analysis From Select Sickle Cell Centers
-
CLINICAL_TRIALS study record update · 2023-04-12Pilot Study of Vitamin D Therapy to Prevent Respiratory Complications in Children With Sickle Cell Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-04-07Peripheral Blood Stem Cell Collection From Patients With Sickle Cell Disease (SCD) Using Plerixafor
-
CLINICAL_TRIALS study record update · 2023-04-05Neuropathic Pain in Jamaicans With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2023-03-23Transfusion Alternatives Pre-operatively in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2023-03-21Part A: Phase IB, Single Site, Dose-Escalation of SCD-101 and Part B: Randomized, Double-Blind, Placebo-Controlled Crossover of SCD-101 in Adults With Homozygous Sickle Cell Disease or S/Beta 0 Thalassemia.
-
CLINICAL_TRIALS study record update · 2023-03-09Risk Stratification for Clinical Severity of Sickle Cell Disease in Nigeria and Assessment of Efficacy and Safety During Treatment With Hydroxyurea
-
CLINICAL_TRIALS study record update · 2023-03-06Study of Crizanlizumab for Prevention of Silent Cerebral Infarcts in SCA Novartis Investigator Initiated Trial: CSEG101AUS12T
-
CLINICAL_TRIALS study record update · 2023-03-01The Relationship of Transcranial Doppler Velocity With Other Vascular Measurements in Children With Sickle Cell Anaemia
-
CLINICAL_TRIALS study record update · 2023-02-23Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis
-
CLINICAL_TRIALS study record update · 2023-02-13Mindfulness and Yoga Therapy for Acute Pain in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2023-02-13Low Dose Iron Chelation as TReatment of Oxidative Damage in Patients With Sickle Cell Disease: the TROS Study
-
CLINICAL_TRIALS study record update · 2023-02-09Prevalence of Osteoporosis in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2023-02-08Improving Quality by Maintaining Accurate Problems in the Electronic Health Record
-
CLINICAL_TRIALS study record update · 2023-02-03Evaluation of the Lung Capillary Blood Volume in Children With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2023-01-04Effects of Prebiotics on Gut Microbiome in Patients Undergoing Stem Cell Transplants
-
CLINICAL_TRIALS study record update · 2022-12-28Hydroxyurea to Prevent Central Nervous System (CNS) Complications of Sickle Cell Disease in Children
-
CLINICAL_TRIALS study record update · 2022-12-28Effects of Obstructive Sleep Apnea on the Frequency of Vaso-occlusive Crises Events and Bio-physical Markers in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2022-12-14Safety Evaluation of DREPADOM - Home Care Services and Hospitalizations for Sickle Cell Disease Patients
-
CLINICAL_TRIALS study record update · 2022-12-12A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Single-and Multiple-Dose Study Evaluating Safety, Tolerability, and Pharmacokinetics, With an Open-Label Initial Food Effect and CYP3A Drug-Drug Interaction Study, of FTX-6058 in Healthy Adult Subjects, and a Randomized, Double-Blind, Placebo-Controlled Multiple-Dose Study Evaluating, Safety, Tolerability and Pharmacokinetics in Subjects With Sickle Cell Disease (SCD)
-
CLINICAL_TRIALS study record update · 2022-12-08Fitness Intervention Trial in Adults With Sickle Cell Disease (SCD Fit): A Feasibility Study
-
CLINICAL_TRIALS study record update · 2022-12-08Qualitative Survey of Potential Exercise Activity in Adults With Sickle Cell Anemia (SCA)